Government backing supports these buys

Article Excerpt

Both Calian and WELL Health have had a major plus on their side during COVID-19 uncertainty. Specifically, the two get most of their revenue from governments. For Calian, revenue generated from federal departments and agencies currently represent about 69% of the total. And meanwhile, WELL profits from Canada’s government-backed, recession-resilient health-care sector. CALIAN GROUP, $69.90, is a buy. The stock (Toronto symbol CGY; TSINetwork Rating: Extra Risk) (calian.com; Shares o/s: 11.3 million; Market cap: $797.0 million; Dividend yield: 1.6%) lets investors benefit from the Ottawa-based company’s four main operating segments: Advanced Technologies offers products and engineering services for the space, communications, nuclear, agriculture, defence and government sectors. The Health unit manages a network of more than 1,800 healthcare professionals delivering primary care and occupational health services to public- and private-sector clients across Canada. The Learning division provides specialized training services and solutions for the Canadian Armed Forces and others. Information Technology provides support for delivering complex IT and cybersecurity solutions. Calian’s focus on secure Canadian government contracts continues to pay off, especially during the…